Summit Therapeutics SMMT Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by Summit Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The official record: Summit Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Summit Therapeutics's total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Summit Therapeutics's total assets?
- Summit Therapeutics (SMMT) reported total assets of $647.86M in Q1 2026.
- How has Summit Therapeutics's total assets changed year-over-year?
- Summit Therapeutics's total assets increased by 68.8% year-over-year, from $383.82M to $647.86M.
- What is the long-term trend for Summit Therapeutics's total assets?
- Over 5 years (2020 to 2025), Summit Therapeutics's total assets has grown at a 48.9% compound annual growth rate (CAGR), from $102.5M to $751.18M.
- What does total assets mean?
- The sum of everything the company owns, including cash, equipment, and intangible assets.
- How do you interpret total assets?
- An increase generally signals growth in the company's resource base, while a decrease may indicate asset liquidation or impairment.
- How does total assets compare across companies?
- Used to compare the overall scale and capital intensity of companies within the same industry.